WikiLeaks released the secret draft of the healthcare annex to the transparency chapter of the Trans-Pacific Partnership (TPP) on June 10. If the TPP is adopted, the annex would adversely affect national pharmaceutical schemes, such as Australia's Pharmaceutical Benefits Scheme and New Zealand's Pharmaceutical Management Agency (PHARMAC). The TPP is a free trade deal being negotiated by countries on the Pacific rim: the US, Australia, Singapore, New Zealand, Chile, Brunei, Canada, Malaysia, Mexico, Peru, Vietnam and Japan. These countries represent about 40% of global GDP.
North American Free Trade Area
The Trans-Pacific Partnership (TPP) being negotiated between the US and 11 other Pacific Rim nations — including Australia — is a treaty covering regulations and investments. It is being negotiated in secret from the peoples of the affected nations, but not from the corporations that are set to benefit from the deal — as chapters leaked by WikiLeaks reveal. For the US side alone, about 600 corporate representatives are neck deep in the negotiations.